Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5469824

CCn1cc(C(=O)O)c(=O)c2cc(SCCN)cnc21.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.45
CYP2C9 P11712 1/20 0.45
ATP6V1B2 P21281 1/20 0.45
TBXA2R P21731 1/20 0.45
EDNRA P25101 1/20 0.45
TARBP2 Q15633 1/20 0.45
MEN1 O00255 1/20 0.44
ABCC4 O15439 1/20 0.44
PKM P14618 1/20 0.44
PTGS1 P23219 1/20 0.44
KMT2A Q03164 1/20 0.44
CASP1 P29466 1/20 0.44
TSHR P16473 3/20 0.40
HIF1A Q16665 1/20 0.40
ENPP2 Q13822 7/20 0.39
DRD3 P35462 1/20 0.38
KDM4E B2RXH2 5/20 0.38
HSD17B10 Q99714 4/20 0.38
HPGD P15428 4/20 0.38
ALDH1A1 P00352 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5463657 0.95 LMNA (0.48) LMNACYP2C9ATP6V1B2TBXA2REDNRA
Trifluoroacetic Acid SCHEMBL3316561 0.86 LMNA (0.34) LMNACYP2C9ATP6V1B2TBXA2REDNRA
Trifluoroacetic Acid SCHEMBL3973337 0.82 LMNA (0.45) LMNACYP2C9ATP6V1B2TBXA2REDNRA
Trifluoroacetic Acid SCHEMBL3980213 0.81 KDM4E (0.55) LMNAMEN1ABCC4PKMPTGS1
Trifluoroacetic Acid SCHEMBL5479976 0.79 KDM4E (0.47) LMNAMEN1ABCC4PKMPTGS1
SCHEMBL5472039 0.79 LMNA (0.40) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL8195106 0.78 LMNA (0.55) LMNACYP2C9ATP6V1B2TBXA2REDNRA
SCHEMBL3697693 0.74 LMNA (0.54) LMNACYP2C9ATP6V1B2TBXA2REDNRA
Trifluoroacetic Acid SCHEMBL4391023 0.74 KDM4E (0.48) LMNAMEN1KMT2ATSHRHIF1A
Trifluoroacetic Acid SCHEMBL3819812 0.73 KDM4E (0.49) LMNAMEN1KMT2ATSHRDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070213283-A1 Macrolides substituted at the 4\"-position GLAXO GROUP LIMITED (GB) 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213283-A1 Macrolides substituted at the 4\"-position IL4, CYP51A1, IL17A LMNA 2144/4885CYP2C9 88/4885ATP6V1B2 4643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.